Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Tuesday, October 20, 2026

Back to today

Vicor Update, Part Three

Vicor’s $66.6 million in AI power-delivery royalties generated about $50 million of operating profit, eclipsing its module business as revenue reached $197.1 million.

VICR $9.7B
CV's Substack 28 clicks

From X

@BrokenMoats 1 click

Broken Moats on X

$PEGA numbers begin the software back to earth story....expect sick to be down significantly tomorrow (it never trades true until the open). The backlog is down QoQ and we are talking 6% ACV now versus guide for 15% at the start of the year. Without a total break from recent trends they will need an absolute monstrous Q4 (comping against a very strong Q4 number yoy coming up) otherwise the backlog number will drop out and that will move from an inflated 15% yoy (from the Q4 25') probably to low single digits or worse..... Big portions of software is in trouble, this is the very beginning
@AsifSuria

Asif Suria on X

On the public company side, I have been looking into the boring company Mueller Water Products $MWA that makes things like fire hydrants. Yes, there is a data center angle but that part of their business is currently small. It showed up on my radar because of insider buying by an independent board member though a 10b5-1 plan. This director previously spent nearly 24 years at Morgan Stanley rising up to the position of Managing Director and Co-Head of Mergers & Acquisitions (Americas). Has an MBA from @UChicago and currently teaches at University of Virginia.

Investor Letters

All letters

LXS.DE: a 2028 sale it can force

Lanxess can force Advent to buy at least half its Envalior stake in April 2028, potentially raising about €745 million to reduce net debt.

LPTH $525M
Trade Ideas Flow 21 clicks

Build-A-Bear: A Narrower Path

Build-A-Bear's push into prestuffed toys and broader retail distribution tests brand stretchability, but recent results warrant caution.

BBW $303M
TSOH Investment Research 18 clicks
KHTRF · long

Knight Therapeutics INC

Knight Therapeutics (GUD-T) is a long position built on confidence in founder Jonathan Goodman, following his earlier success with Paladin…

KHTRF $826M
Value Investors Club 2 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 54 of 245

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

90 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.